185 related articles for article (PubMed ID: 1751757)
1. The study of fibrin polymerization with monoclonal antibodies.
Lugovskoi EV; Makogonenko EM; Chudnovets VS; Derzskaya SG; Gogolinskaya GK; Kolesnikova IN; Bukhanevich AM; Sitak IN; Lyashko ED; Komissarenko SV
Biomed Sci; 1991; 2(3):249-56. PubMed ID: 1751757
[TBL] [Abstract][Full Text] [Related]
2. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
Weisel JW; Veklich Y; Gorkun O
J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
[TBL] [Abstract][Full Text] [Related]
3. [Study of the polymerization of fibrin using monoclonal antibodies 2D-2A and their Fab-fragments].
Lugovskoĭ EV; Chudnovets VS; Makogonenko EM; Derzskaia SG; Gogolinskaia GK; Kolesnikova IN; Mikhalovskaia LI; Komissarenko SV
Ukr Biokhim Zh (1978); 1995; 67(1):64-70. PubMed ID: 8588256
[TBL] [Abstract][Full Text] [Related]
4. Functional role of Bbeta-chain N-terminal fragment in the fibrin polymerization process.
Lugovskoy EV; Gritsenko PG; Kapustianenko LG; Kolesnikova IN; Chernishov VI; Komisarenko SV
FEBS J; 2007 Sep; 274(17):4540-9. PubMed ID: 17681017
[TBL] [Abstract][Full Text] [Related]
5. Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization.
Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Zolotarova EN; Chernishov VI; Nieuwenhuizen W; Komisarenko SV
Thromb Res; 2004; 113(3-4):251-9. PubMed ID: 15140590
[TBL] [Abstract][Full Text] [Related]
6. A neoantigenic determinant in coiled coil region of human fibrin beta-chain.
Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Lugovskaya NE; Komisarenko SV
Thromb Res; 2009 Mar; 123(5):765-70. PubMed ID: 18977516
[TBL] [Abstract][Full Text] [Related]
7. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
8. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization.
Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS
Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826
[TBL] [Abstract][Full Text] [Related]
9. Release of fibrinopeptides by the slow and fast forms of thrombin.
Vindigni A; Di Cera E
Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
[TBL] [Abstract][Full Text] [Related]
10. Localization of an effective fibrin beta-chain polymerization site: implications for the polymerization mechanism.
Hsieh Kh
Biochemistry; 1997 Aug; 36(31):9381-7. PubMed ID: 9235981
[TBL] [Abstract][Full Text] [Related]
11. Cloning of the complete coding sequence of rat fibrinogen B beta chain cDNA: interspecies conservation of fibrin beta 15-42 primary structure.
Courtney MA; Bunce LA; Neroni LA; Simpson-Haidaris PJ
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):487-96. PubMed ID: 7841303
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly.
Mosesson MW
Blood Coagul Fibrinolysis; 1997 Jul; 8(5):257-67. PubMed ID: 9282789
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
Raut S; Gaffney PJ
Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252
[TBL] [Abstract][Full Text] [Related]
15. Availability of the B beta(15-21) epitope on cross-linked human fibrin and its plasmic degradation products.
Chen F; Haber E; Matsueda GR
Thromb Haemost; 1992 Mar; 67(3):335-40. PubMed ID: 1379385
[TBL] [Abstract][Full Text] [Related]
16. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
17. Twofold symmetry of human fibrinogen proved at the beta chain distal domains by monoclonal-immunoelectron microscopy and image analysis.
Méndez JA; Alvarez MV; Aznárez JA; González-Rodríguez J
Biochemistry; 1996 Jan; 35(2):634-7. PubMed ID: 8555237
[TBL] [Abstract][Full Text] [Related]
18. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
[TBL] [Abstract][Full Text] [Related]
19. The ultrastructure of fibrinogen-420 and the fibrin-420 clot.
Mosesson MW; DiOrio JP; Hernandez I; Hainfeld JF; Wall JS; Grieninger G
Biophys Chem; 2004 Dec; 112(2-3):209-14. PubMed ID: 15572250
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.
Mao SJ; Rechtin AE; Krstenansky JL; Jackson RL
Thromb Haemost; 1990 Jun; 63(3):445-8. PubMed ID: 2402748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
